A study identified that FGF21 levels were increased at the early stage of hepatic stress in a genetic model mouse presenting diabetes-steatohepatitis (27); however, the reduction in FGF21 levels was reported when HCC was well-developed. Here, FGF21 is linked to hepatocellular carcinoma.